PharmaShots | Incisive News in 3 Shots

Subscribe Now

GalXC RNAi

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

May 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us